Stocks To Buy Now

Blog


Algae Dynamics Corp. (ADYNF) Focuses on Cannabis Oil Vision for Medicinal Applications

  • The Canadian cannabis oil extraction market is projected to reach $1.5 billion by 2020
  • Algae Dynamics is focused on extracting cannabis and hemp oil, which has a range of medicinal health benefits
  • Cannabis oil extracts act on the human endocannabinoid system, which includes receptors in the brain, organs, and tissues

The oils extracted from cannabis plants, especially those with high levels of cannabidiol (CBD), have been used for medicinal purposes for millennia. Algae Dynamics Corp. (OTCQB: ADYNF) has been focused on cannabis oil extraction, part of its vision to become a world leader in this field. A $1 million market in Canada in 2015, the oil extraction market is anticipated to hit $1.5 billion by 2020. Full legalization is expected across the country by July 2018, and research into the Colorado market, one of the first legal cannabis markets in the U.S., has led to estimates of 45 percent of users converting from dried marijuana to extracts and oil. The market value projections are based on similar anticipated trends for the Canadian market.

By extracting the oil from cannabis, the company aims to develop a range of health products from its derivatives. Cannabis oil, according to CBD International (http://dtn.fm/5OdC4), is beneficial for various health conditions and illnesses. The focus is cannabidiol, one of the main ingredients in marijuana. The other is tetrahydrocannabinol (THC), which is responsible for the psychotropic effects of cannabis. On the other hand, CBD does not produce a high and has been used to treat pain and epileptic seizures, as well as to slow the effects of Alzheimer’s disease. Studies have shown CBD to act on the enzymes that form amyloid plaques in the brain, which kill brain cells in people with the disease, with CBD believed to slow down this progression.

Also, CBD has antioxidant effects that can help improve heart health. It can ease pain associated with multiple sclerosis as well. Other effects of cannabis oil include boosting appetite, treating inflammatory bowel diseases such as Crohn’s disease and ulcerative colitis, and inducing a longer, more restful sleep. It’s been used to manage conditions such as anxiety, glaucoma, post-traumatic stress disorder and cancer.

Algae Dynamics Corp. is highly focused on cannabis oil extraction. Complementing it with Omega-3 oils from algae to boost the effectiveness of medicinal cannabis oils, this effort is helping the company take advantage of the traction cannabis has gained for medicinal purposes. This has been the focus of the company’s strategy for 2017, which has included university research agreements, application for a Health Canada license and supplying oil extraction equipment for the built-out oil extraction room at Bonify’s facility (a private Licensed Producer and partner).

The extracts play a significant role in human physiology. There are plant-derived cannabinoids, or phytocannabinoids, and ones produced in the human body, known as endocannabinoids. Known since the 1960s, cannabinoids have demonstrated numerous links to maintaining health. In 1992, the biological endocannabinoid system was discovered, further substantiating this connection. These compounds and their receptors are found in the brain, glands, organs, immune cells and connective tissues, leading to the development of cannabis-based oils with a number of reported health benefits.

As mentioned above, the company recently partnered with Bonify to extract cannabis oils and develop cannabis oil products (http://dtn.fm/AcEo7), with revenue to be generated from the cannabis oils the company extracts at Bonify.

For more information, visit the company’s website at www.AlgaeDynamics.com

Let us hear your thoughts: Algae Dynamics Corp. Message Board

Latest From Twitter

Follow us: @Buy_Stocks_Now

From Our Blog

India Globalization Capital, Inc. (NYSE: IGC) Reports Promising Progress of Cannabis-Based Alzheimer’s Drug Candidate

September 18, 2017

IGC is the only publicly traded cannabis stock with patent filings for treating Alzheimer’s disease Company has a first-mover advantage in phytocannabinoid-based combination therapy Alzheimer’s is America’s most expensive disease, costing the country an estimated $259 billion in 2017 It is considered America’s most expensive disease, projected to cost an estimated $259 billion in the […]

Rotate your device 90° to view site.